INDICATIONS
Brimonidine tartrate is indicated for lowering pressure
in patients with open-angle glaucoma or ocular hypertension.
The IOP lowering efficacy of brimonidine tartrate ophthalmic
solution diminishes over time in some patients. This loss
of effect appears with a variable time of onset in each
patient and should be closely monitored.
DOSAGE AND ADMINISTRATION
The recommended dose is one drop of brimonidine tartrate
in the affected eye(s) three times daily, approximately
8 hours apart.
HOW SUPPLIED
Alphagan 0.2% is supplied sterile in white opaque plastic
dropper bottles.
Storage: Store at or below 25°C
(77°F).
PRODUCT LISTING
| Solution
- Ophthalmic - 0.2% |
| 5 ml |
Alphagan Ophthalmic Solution,
Allergan |
00023-8665-05 |
| 10 ml |
Alphagan Ophthalmic Solution,
Allergan |
00023-8665-10 |
| 15 ml |
Alphagan Ophthalmic Solution,
Allergan |
00023-8665-15 |
| 
